Crinetics Pharmaceuticals IncNASDAQ:CRNX
- LAST PRICE57.0400
- TODAY'S CHANGE (%)0.3500 (0.6174%)
- Bid / Lots57.0100/ 1
- Ask / Lots57.0700/ 2
- Open / Previous Close56.1700 / 56.6900
- Day Range
- 52 Week Range
- Volume245,977
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRNX |
|---|---|---|
| 09:32 ET | 2217 | 56.17 |
| 09:33 ET | 300 | 55.81 |
| 09:35 ET | 170 | 55.96 |
| 09:37 ET | 100 | 55.465 |
| 09:42 ET | 100 | 55.65 |
| 09:44 ET | 200 | 55.45 |
| 09:46 ET | 100 | 55.45 |
| 09:48 ET | 2057 | 55.84 |
| 09:50 ET | 499 | 55.685 |
| 09:51 ET | 100 | 55.58 |
| 09:53 ET | 210 | 55.49 |
| 09:55 ET | 578 | 55.5 |
| 09:57 ET | 1200 | 55.54 |
| 10:00 ET | 100 | 55.56 |
| 10:02 ET | 400 | 55.36 |
| 10:04 ET | 200 | 55.415 |
| 10:06 ET | 200 | 55.41 |
| 10:08 ET | 2994 | 55.21 |
| 10:09 ET | 1100 | 55.44 |
| 10:11 ET | 2644 | 55.42 |
| 10:13 ET | 1220 | 55.63 |
| 10:15 ET | 200 | 55.85 |
| 10:22 ET | 560 | 56.035 |
| 10:26 ET | 600 | 56.05 |
| 10:27 ET | 1234 | 56.1489 |
| 10:29 ET | 300 | 56.055 |
| 10:31 ET | 384 | 56.045 |
| 10:33 ET | 200 | 56.03 |
| 10:36 ET | 100 | 55.95 |
| 10:38 ET | 600 | 56 |
| 10:40 ET | 200 | 56.07 |
| 10:42 ET | 300 | 56.01 |
| 10:44 ET | 500 | 56.07 |
| 10:45 ET | 2167 | 56.28 |
| 10:47 ET | 950 | 56.16 |
| 10:49 ET | 602 | 56.31 |
| 10:54 ET | 351 | 56.285 |
| 10:56 ET | 200 | 56.3 |
| 10:58 ET | 1010 | 56.39 |
| 11:00 ET | 200 | 56.425 |
| 11:02 ET | 800 | 56.5 |
| 11:05 ET | 2129 | 56.74 |
| 11:09 ET | 1288 | 56.855 |
| 11:12 ET | 100 | 56.94 |
| 11:14 ET | 543 | 57.01 |
| 11:18 ET | 500 | 57 |
| 11:20 ET | 300 | 56.94 |
| 11:23 ET | 300 | 56.86 |
| 11:25 ET | 200 | 56.77 |
| 11:30 ET | 100 | 56.855 |
| 11:34 ET | 200 | 56.875 |
| 11:36 ET | 300 | 56.95 |
| 11:38 ET | 200 | 56.89 |
| 11:39 ET | 100 | 56.9 |
| 11:41 ET | 100 | 56.86 |
| 11:43 ET | 500 | 56.88 |
| 11:45 ET | 400 | 56.77 |
| 11:48 ET | 100 | 56.85 |
| 11:50 ET | 200 | 56.79 |
| 11:52 ET | 100 | 56.84 |
| 11:54 ET | 613 | 56.76 |
| 11:56 ET | 100 | 56.71 |
| 11:57 ET | 100 | 56.62 |
| 12:01 ET | 100 | 56.57 |
| 12:08 ET | 100 | 56.57 |
| 12:15 ET | 300 | 56.5804 |
| 12:17 ET | 100 | 56.64 |
| 12:19 ET | 100 | 56.655 |
| 12:21 ET | 1027 | 56.79 |
| 12:24 ET | 1079 | 56.87 |
| 12:26 ET | 1056 | 56.86 |
| 12:28 ET | 100 | 56.85 |
| 12:32 ET | 200 | 56.855 |
| 12:33 ET | 200 | 56.855 |
| 12:37 ET | 810 | 56.87 |
| 12:39 ET | 460 | 56.885 |
| 12:42 ET | 400 | 57.01 |
| 12:44 ET | 200 | 56.98 |
| 12:51 ET | 500 | 57.1 |
| 12:55 ET | 751 | 57.13 |
| 12:57 ET | 1100 | 56.96 |
| 01:00 ET | 3278 | 57.03 |
| 01:02 ET | 490 | 56.97 |
| 01:04 ET | 300 | 56.89 |
| 01:06 ET | 300 | 56.79 |
| 01:08 ET | 300 | 56.76 |
| 01:09 ET | 200 | 56.76 |
| 01:11 ET | 102 | 56.79 |
| 01:13 ET | 300 | 56.85 |
| 01:15 ET | 3402 | 56.86 |
| 01:18 ET | 100 | 56.98 |
| 01:20 ET | 300 | 57.07 |
| 01:24 ET | 100 | 57.01 |
| 01:26 ET | 362 | 56.963 |
| 01:27 ET | 100 | 57.05 |
| 01:29 ET | 100 | 56.96 |
| 01:31 ET | 100 | 57.01 |
| 01:33 ET | 538 | 57.07 |
| 01:36 ET | 625 | 57.08 |
| 01:38 ET | 200 | 57.08 |
| 01:42 ET | 200 | 57.13 |
| 01:44 ET | 100 | 57.13 |
| 01:45 ET | 2106 | 56.89 |
| 01:54 ET | 958 | 56.89 |
| 01:58 ET | 400 | 56.835 |
| 02:00 ET | 1200 | 56.8 |
| 02:02 ET | 400 | 56.82 |
| 02:05 ET | 100 | 56.78 |
| 02:07 ET | 400 | 56.75 |
| 02:09 ET | 100 | 56.805 |
| 02:14 ET | 861 | 56.905 |
| 02:16 ET | 1172 | 56.8422 |
| 02:18 ET | 300 | 56.84 |
| 02:20 ET | 100 | 56.875 |
| 02:21 ET | 100 | 56.875 |
| 02:23 ET | 600 | 56.94 |
| 02:27 ET | 100 | 56.93 |
| 02:30 ET | 300 | 56.97 |
| 02:32 ET | 200 | 56.98 |
| 02:34 ET | 400 | 57.035 |
| 02:36 ET | 400 | 57.04 |
| 02:38 ET | 243 | 57.06 |
| 02:39 ET | 100 | 57.045 |
| 02:41 ET | 1000 | 57 |
| 02:43 ET | 1126 | 57.02 |
| 02:50 ET | 100 | 57.035 |
| 02:54 ET | 2256 | 57.235 |
| 02:56 ET | 100 | 57.21 |
| 02:57 ET | 3088 | 57.14 |
| 02:59 ET | 701 | 57.24 |
| 03:01 ET | 400 | 57.245 |
| 03:03 ET | 500 | 57.25 |
| 03:06 ET | 500 | 57.26 |
| 03:08 ET | 1413 | 57.264658 |
| 03:10 ET | 200 | 57.2625 |
| 03:12 ET | 3848 | 57.1 |
| 03:14 ET | 702 | 57.1 |
| 03:15 ET | 1100 | 57.13 |
| 03:17 ET | 400 | 57.05 |
| 03:19 ET | 1319 | 57.0767 |
| 03:21 ET | 515 | 57.1 |
| 03:24 ET | 1507 | 57.1 |
| 03:26 ET | 1936 | 57.14 |
| 03:28 ET | 7922 | 57.5 |
| 03:30 ET | 1200 | 57.38 |
| 03:32 ET | 4310 | 57.15 |
| 03:33 ET | 1950 | 57.19 |
| 03:35 ET | 1257 | 57.105 |
| 03:37 ET | 400 | 57.1 |
| 03:39 ET | 3198 | 57.015 |
| 03:42 ET | 700 | 57.17 |
| 03:44 ET | 1200 | 57.28 |
| 03:46 ET | 1110 | 57.235 |
| 03:48 ET | 1909 | 57.24 |
| 03:50 ET | 11092 | 57.06 |
| 03:51 ET | 7277 | 57.08 |
| 03:53 ET | 4722 | 57.035 |
| 03:55 ET | 9813 | 57.04 |
Oct 16, 2024
Crinetics Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 12, 2024, from 8:00AM ET on Wednesday Oct 16, 2024 by Dow Jones
8:00AM ET on Wednesday Oct 16, 2024 by Dow Jones
Oct 10, 2024
Crinetics Pharmaceuticals Announces October 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:40PM ET on Thursday Oct 10, 2024 by Dow Jones
4:40PM ET on Thursday Oct 10, 2024 by Dow Jones
Oct 9, 2024
*DJ Crinetics Pharmaceuticals Prices Upsized Public Offering of Shares at $50 Each >CRNX, from 12:02AM ET on Wednesday Oct 09, 2024 by Dow Jones
12:02AM ET on Wednesday Oct 09, 2024 by Dow Jones
Oct 8, 2024
Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock, from 11:55PM ET on Tuesday Oct 08, 2024 by Dow Jones
11:55PM ET on Tuesday Oct 08, 2024 by Dow JonesDJ Crinetics Pharmaceuticals Selling Up to $460M in Shares, from 4:14PM ET on Tuesday Oct 08, 2024 by Dow Jones
4:14PM ET on Tuesday Oct 08, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Crinetics Pharmaceuticals Inc | 5.1B | -15.1x | --- |
Biohaven Ltd | 5.0B | -5.5x | --- |
Avidity Biosciences Inc | 4.9B | -15.3x | --- |
Krystal Biotech Inc | 5.1B | 47.1x | --- |
BridgeBio Pharma Inc | 4.8B | -9.6x | --- |
Nuvalent Inc | 5.8B | -32.1x | --- |
Company Information
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Contact Information
- Headquarters
- 10222 Barnes Canyon Rd Bldg 2SAN DIEGO, CA, United States 92121-2711
- Phone
- 858-450-6464
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Wendell Wierenga
- President, Chief Executive Officer, Co-Founder, Director
- R. Scott Struthers
- Co-Founder, Chief Scientific Officer
- Stephen Betz
- Chief Financial Officer
- Marc Wilson
- Chief Operating Officer
- Jeff Knight
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.1B |
|---|---|
Revenue (TTM) | $1.4M |
Shares Outstanding | 89.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.61 |
EPS | $-3.77 |
Book Value | $7.91 |
P/E Ratio | -15.1x |
Price/Sales (TTM) | 3,656.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -20,068.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
